RE Champlin

4.4k total citations · 1 hit paper
50 papers, 3.4k citations indexed

About

RE Champlin is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, RE Champlin has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 16 papers in Oncology and 10 papers in Surgery. Recurrent topics in RE Champlin's work include Hematopoietic Stem Cell Transplantation (27 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). RE Champlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). RE Champlin collaborates with scholars based in United States, Germany and United Kingdom. RE Champlin's co-authors include DW Golde, Gale Rp, MM Horowitz, DW van Bekkum, Good Ra, RC Ash, A Marmont, BM Camitta, Éliane Gluckman and Dicke Ka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

RE Champlin

50 papers receiving 3.3k citations

Hit Papers

T-cell depletion of HLA-identical transplants in leukemia 1991 2026 2002 2014 1991 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. T-cell depletion of HLA-identical transplants in leukemia
    1991 581 citations MM Horowitz, Gale Rp et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RE Champlin United States 28 2.7k 1.0k 912 869 531 50 3.4k
R Storb United States 25 2.6k 1.0× 833 0.8× 791 0.9× 602 0.7× 546 1.0× 47 3.3k
K Lilleby United States 24 2.8k 1.1× 1.6k 1.5× 840 0.9× 639 0.7× 290 0.5× 38 3.7k
Giuseppe Bandini Italy 29 2.4k 0.9× 797 0.8× 1.1k 1.2× 795 0.9× 422 0.8× 134 3.4k
HJ Kolb Germany 18 3.4k 1.3× 925 0.9× 1.9k 2.1× 792 0.9× 772 1.5× 30 4.4k
AB Deisseroth United States 33 2.0k 0.8× 838 0.8× 523 0.6× 683 0.8× 405 0.8× 69 3.0k
Taner Demirer Türkiye 31 2.2k 0.8× 1.2k 1.1× 763 0.8× 512 0.6× 261 0.5× 101 3.2k
HJ Kolb Germany 22 2.9k 1.1× 810 0.8× 1.5k 1.6× 620 0.7× 653 1.2× 50 3.7k
Peter Kalhs Austria 34 2.4k 0.9× 573 0.6× 1.1k 1.2× 478 0.6× 472 0.9× 119 3.3k
Karel A. Dicke United States 32 2.1k 0.8× 1.3k 1.3× 519 0.6× 489 0.6× 419 0.8× 108 3.5k
A Schattenberg Netherlands 26 3.0k 1.1× 1.2k 1.1× 1.7k 1.9× 629 0.7× 536 1.0× 77 4.0k

Countries citing papers authored by RE Champlin

Since Specialization
Citations

This map shows the geographic impact of RE Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Champlin more than expected).

Fields of papers citing papers by RE Champlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RE Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Champlin. The network helps show where RE Champlin may publish in the future.

Co-authorship network of co-authors of RE Champlin

This figure shows the co-authorship network connecting the top 25 collaborators of RE Champlin. A scholar is included among the top collaborators of RE Champlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RE Champlin. RE Champlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Körbling, M, Sydney K. Robinson, Zeev Estrov, RE Champlin, & Elizabeth J. Shpall. (2005). Umbilical cord blood-derived cells for tissue repair. Cytotherapy. 7(3). 258–261. 20 indexed citations
2.
Anagnostopoulos, Αchilles, Ying Yang, Michèle L. Donato, et al.. (2004). Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy. Bone Marrow Transplantation. 33(6). 623–628. 12 indexed citations
3.
Champlin, RE. (2003). Addition of antithymocyte globulin (ATG) to cyclophosphamide (Cy) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anemia (SAA) : results of a randomized controlled trial. Blood. 102. 3 indexed citations
4.
Anderlini, P, et al.. (2002). Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplantation. 30(10). 661–663. 40 indexed citations
5.
6.
Konoplev, Sergej, RE Champlin, Sergio Giralt, et al.. (2001). Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplantation. 27(8). 877–881. 77 indexed citations
7.
8.
Gajewski, James, Michèle L. Donato, Sergio Giralt, et al.. (2000). Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy). Bone Marrow Transplantation. 25(S2). S35–S38. 34 indexed citations
9.
10.
Anderlini, P, Sergio Giralt, Börje S. Andersson, et al.. (2000). Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease. Bone Marrow Transplantation. 26(6). 615–620. 66 indexed citations
11.
Abbott, Brian L., Cindy Ippoliti, J Bruton, et al.. (1999). Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation. Bone Marrow Transplantation. 23(3). 265–269. 24 indexed citations
12.
Ippoliti, Cindy, et al.. (1999). Toxicity of single daily dose gentamicin in stem cell transplantation. Bone Marrow Transplantation. 24(1). 57–61. 9 indexed citations
13.
Besien, Koen van, Marcos de Lima, Gabriela Rondón, et al.. (1997). Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplantation. 19(10). 977–982. 175 indexed citations
14.
Champlin, RE. (1995). Optimizing the Composition of Bone Marrow for Allogeneic Transplantation. Journal of Hematotherapy. 4(1). 53–60. 4 indexed citations
15.
16.
17.
18.
Horowitz, MM, Donna Przepiorka, RE Champlin, et al.. (1992). Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? [see comments]. Blood. 79(10). 2771–2774. 43 indexed citations
19.
Champlin, RE & DW Golde. (1985). Chronic myelogenous leukemia: recent advances. Blood. 65(5). 1039–1047. 158 indexed citations
20.
Champlin, RE, et al.. (1985). Recombinant alpha-2-interferon for hairy cell leukemia. Blood. 65(4). 1017–1020. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Storb Breakdown of academic impact, for papers by K Lilleby Breakdown of academic impact, for papers by Giuseppe Bandini Breakdown of academic impact, for papers by HJ Kolb Breakdown of academic impact, for papers by AB Deisseroth Breakdown of academic impact, for papers by Taner Demirer Breakdown of academic impact, for papers by HJ Kolb Breakdown of academic impact, for papers by Peter Kalhs Breakdown of academic impact, for papers by Karel A. Dicke Breakdown of academic impact, for papers by A Schattenberg
Rankless by CCL
2026